NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ — Kos Biotechnology Partners (“Kos”), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced the third closing of its inaugural global life sciences fund, bringing total capital…
Welcome to the Healthcare Insights Desk at TheUnplanned.in, where we delve deep into the world of health and wellness. Our dedicated team of writers brings you authoritative articles, expert opinions, and insightful analyses on all facets of healthcare.
Discover more from The Unplanned
Subscribe to get the latest posts sent to your email.
